Literature DB >> 15766575

Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system.

Masanori Ikeda1, Ken-Ichi Abe, Hiromichi Dansako, Takashi Nakamura, Kazuhito Naka, Nobuyuki Kato.   

Abstract

Recently we reported a subgenomic hepatitis C virus (HCV) replicon derived from HCV (HCV-O strain) infected in non-neoplastic human hepatocyte PH5CH8. In this study, we developed a genome-length dicistronic HCV RNA from HCV-O. A cured HuH-7 cell line (sOc) was obtained from a cloned subgenomic replicon cell line (sO) by interferon (IFN) treatment and used for transfection with genome-length HCV RNA. One cloned cell line, O, was successfully selected by G418 treatment following the introduction of genome-length HCV RNA into sOc cells, and the robust expression of HCV RNA and proteins was confirmed. Oc, a cured cell line, was also obtained from the cloned cell line (O) by IFN treatment. The number of colonies increased drastically when genome-length HCV RNA was introduced into Oc cells. However, the cloned cured cell lines, sOc and Oc, differed in their colony formation efficiency despite their common origin. This result suggests that even a cloned cell line can change its characteristics during cell culture. Sequence analysis of HCV RNA from the O cells revealed an amino acid substitution in the NS3 helicase region (K1609E). This substitution worked as an adaptive mutation in transient reporter and colony formation assays. Using the advantages of this adaptive mutation and of Oc cells in colony formation, we established the first cell line in which genome-length dicistronic HCV RNA encoding a luciferase gene replicated efficiently. This culture system is useful tool for the study of HCV replication and mass screening for anti-HCV reagents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15766575     DOI: 10.1016/j.bbrc.2005.02.138

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  62 in total

1.  Cytoplasmic dsRNA induces the expression of OCT3/4 and NANOG mRNAs in differentiated human cells.

Authors:  Guanming Wang; Takahisa Kouwaki; Kazuki Mugikura; Masaaki Okamoto; Hiromi Takaki; Kenji Funami; Tsukasa Seya; Hiroyuki Oshiumi
Journal:  J Biol Chem       Date:  2019-10-15       Impact factor: 5.157

2.  Cell-based Assays to Identify Inhibitors of Viral Disease.

Authors:  Neil Green; Robert D Ott; Richard J Isaacs; Hong Fang
Journal:  Expert Opin Drug Discov       Date:  2008-06-01       Impact factor: 6.098

3.  A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus.

Authors:  Hong Zhao; Wenyu Lin; Kattareeya Kumthip; Du Cheng; Dahlene N Fusco; Oliver Hofmann; Nikolaus Jilg; Andrew W Tai; Kaku Goto; Leiliang Zhang; Winston Hide; Jae Young Jang; Lee F Peng; Raymond T Chung
Journal:  J Hepatol       Date:  2011-08-31       Impact factor: 25.083

4.  Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening.

Authors:  Weidong Hao; Koleen J Herlihy; Noelle Jie Zhang; Shella A Fuhrman; Chau Doan; Amy K Patick; Rohit Duggal
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

5.  The spliceosome factor SART1 exerts its anti-HCV action through mRNA splicing.

Authors:  Wenyu Lin; Chuanlong Zhu; Jian Hong; Lei Zhao; Nikolaus Jilg; Dahlene N Fusco; Esperance A Schaefer; Cynthia Brisac; Xiao Liu; Lee F Peng; Qikai Xu; Raymond T Chung
Journal:  J Hepatol       Date:  2014-12-03       Impact factor: 25.083

Review 6.  Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.

Authors:  Qing Liu; Stig Bengmark; Shen Qu
Journal:  BMC Gastroenterol       Date:  2010-05-20       Impact factor: 3.067

7.  A functional genomic screen identifies cellular cofactors of hepatitis C virus replication.

Authors:  Andrew W Tai; Yair Benita; Lee F Peng; Sun-Suk Kim; Naoya Sakamoto; Ramnik J Xavier; Raymond T Chung
Journal:  Cell Host Microbe       Date:  2009-03-19       Impact factor: 21.023

8.  Hepatitis C virus NS4B targets lipid droplets through hydrophobic residues in the amphipathic helices.

Authors:  Torahiko Tanaka; Kazumichi Kuroda; Masanori Ikeda; Takaji Wakita; Nobuyuki Kato; Makoto Makishima
Journal:  J Lipid Res       Date:  2013-01-12       Impact factor: 5.922

9.  Artesunate, an anti-malarial drug, has a potential to inhibit HCV replication.

Authors:  Rongjuan Dai; Xinqiang Xiao; Feng Peng; Mingming Li; Guozhong Gong
Journal:  Virus Genes       Date:  2016-01-06       Impact factor: 2.332

10.  Cyclosporine inhibits a direct interaction between cyclophilins and hepatitis C NS5A.

Authors:  Fiona Fernandes; Israr-ul H Ansari; Rob Striker
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.